Periprocedural Coumadin Management

摘要

We have recently been following BCD, a 58-year-old male who was diagnosed with a first unprovoked deep vein thrombosis (DVT). After completing 3 months of treatment with warfarin, KD elected to continue warfarin therapy indefinitely in order to reduce his risk for a future DVT or pulmonary embolism (PE).KD has had consistently therapeutic international normalized ratios (INRs) and has not experienced any problems with his warfarin therapy. However, in 2 weeks, he is scheduled to undergo a screening colonoscopy that he had originally avoided when offered at age 50.,